TipRanks
Advertisement
Advertisement
IDEAYA Biosciences: Strategic Oncology Collaborations and Strong Cash Position Support Buy Rating with Unchanged $58 Price Target
PremiumRatingsIDEAYA Biosciences: Strategic Oncology Collaborations and Strong Cash Position Support Buy Rating with Unchanged $58 Price Target
2M ago
Ideaya Biosciences enters IDE892 collaboration with Genentech
Premium
The Fly
Ideaya Biosciences enters IDE892 collaboration with Genentech
2M ago
Ideaya Biosciences price target lowered to $42 from $45 at Citizens
Premium
The Fly
Ideaya Biosciences price target lowered to $42 from $45 at Citizens
2M ago
Ideaya Biosciences initiates monotherapy expansion in IDE892 trial
PremiumThe FlyIdeaya Biosciences initiates monotherapy expansion in IDE892 trial
3M ago
Ideaya Biosciences price target lowered to $63 from $65 at Truist
Premium
The Fly
Ideaya Biosciences price target lowered to $63 from $65 at Truist
3M ago
Ideaya Biosciences price target lowered to $48 from $53 at RBC Capital
Premium
The Fly
Ideaya Biosciences price target lowered to $48 from $53 at RBC Capital
3M ago
IDEAYA Biosciences Raises $324 Million in Equity Offering
PremiumCompany AnnouncementsIDEAYA Biosciences Raises $324 Million in Equity Offering
4M ago
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
Premium
The Fly
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
4M ago
Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates
Premium
The Fly
Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―